08 diciembre 2008

Pharma Mar presenta este año Cuatro resultados Hematologicos en el Congreso ASH ( EEUU ) de sus Farmacos Aplidin e Zalypsis . 6 al 9 December 2008 .

Velcade + Dexamethasone + Cyclophosphamide and lenalidomide , resultados en Multiple Myeloma en Pacientes NO tratados , fases I - II .

Velcade . Blood-Cancer Drug Hits $1 Billion .

Year-to-date sales of blood-cancer drug Velcade hit $1 billion in November, indicating the medicine's sales grew more than 25% in a year that saw broadened approval from the Food and Drug Administration ...